France has allowed international travelers who have received the Covishield, AstraZeneca’s Indian-manufactured vaccine, into the country from Sunday (July 17) onwards.
The move to accept visitors vaccinated with AstraZeneca’s vaccine made by India’s Serum Institute came after a global outcry over the fact that the European Union’s COVID-19 certificate for travel only recognized AstraZeneca vaccines manufactured in Europe.
Recently, the EU launched the “Green Pass” programme, which would allow travellers who have been vaccinated with an approved set of vaccines to travel inside the EU’s 27-country zone.
Here is the full list of countries which have given recognition to Covishield for international travel:
Antigua and Barbuda
Bolivia (Plurinational State of)
Saint Kitts and Nevis
Saint Vincent and the Grenadines
Trinidad and Tobago
India had begun its vaccination drive on January 16 this year, with the AstraZeneca-Oxford vaccine ‘Covishield’, locally manufactured by the Serum Institute of India, and Covaxin, made by Bharat Biotech.
Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) said it was good news that Covishield, the Indian version of the 16 European countries now recognised and accepted Oxford-Astrazeneca vaccine for entry of international travellers.
However, he cautioned travellers to follow travel advisories that differ from country to country.
“It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for entry. However, despite being vaccinated, entry guidelines might vary from country to country, so do read up before you travel,” tweeted Poonawalla.